Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
50%(4 trials)

Phase Distribution

Ph phase_1
2
25%
Ph phase_2
1
13%
Ph phase_3
5
63%

Phase Distribution

2

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
5(62.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (25.0%)
Phase 21 (12.5%)
Phase 35 (62.5%)

Trials by Status

completed8100%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_3

PA21 Safety and Efficacy in Adult Chinese Subjects

NCT03644264
completedphase_3

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

NCT01850602
completedphase_3

A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia

NCT01850641
completedphase_3

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

NCT01833494
completedphase_2

PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia

NCT01521494
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03644264Phase 3

PA21 Safety and Efficacy in Adult Chinese Subjects

Completed
NCT01850602Phase 3

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Completed
NCT01850641Phase 3

A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia

Completed
NCT01833494Phase 3

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Completed
NCT01521494Phase 2

PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia

Completed
NCT01852682Phase 3

A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia

Completed
NCT01477424Phase 1

A Drug-Drug Interaction Study of Warfarin and PA21

Completed
NCT01477411Phase 1

A Drug-Drug Interaction Study of Digoxin and PA21

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8